Entheon Biomedical Corp. announced a private placement of up to 2,950,000 units at a price of CAD 0.05 per unit for gross proceeds of up to CAD 147,500 on April 11, 2024. Each unit will consist of one common share and one transferable share purchase warrant.
Each warrant will be exercisable to acquire one additional share at an exercise price of CAD 0.10 per share for a period of 60 months from the date of issuance. All securities issued under the placement will be subject to a four-month and one-day hold period. The company may pay finder?s fees in accordance with the policies of the Canadian Securities Exchange.